Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.002
Neutral
RSI(14)
63.975
Neutral
STOCH(KDJ)(9,3,3)
58.459
Buy
ATR(14)
0.011
High Vlolatility
CCI(14)
204.061
Overbought
Williams %R
33.333
Buy
TRIX(12,20)
0.072
Sell
StochRSI(14)
71.937
Buy
Search
Forian Inc
FORAAdd to Watchlist
2.170USD
0.0000.00%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
64.01MMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Forian Inc
Currency: USD Updated: 2026-05-14Key Insights
Forian Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 186 out of 470 in the Software & IT Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 2.10.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Forian Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Forian Inc Highlights
StrengthsRisks
Forian Inc. is a healthtech company. The Company is a provider of data science-driven information and analytics solutions to the life science, healthcare and financial services industries. The Company provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure the operational, clinical and financial performance of customers. It has expertise in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. Its data ingestion, transformation, delivery services and business intelligence platforms are managed entirely via cloud-based data centers located in the United States. The Company’s offerings include commercial, Real World Evidence (RWE) and market access solutions and proprietary data-driven insights to optimize the operational, clinical and financial performance of its customers. The Company’s solutions include CHRONOS, Chartis, RWE and Kyber Data Science.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 42.61% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 30.26M.
Fairly Valued
The company’s latest PE is -23.49, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 4.40M shares, increasing 8.00% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 56.00K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.21.
Analyst Rating
Based on
1
analysts
Hold
Current Rating
2.100
Target Price
-3.23%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-05-14Its latest quarterly revenue reached 6.85M, representing a year-over-year decrease of 2.91%, while its net profit experienced a year-over-year decrease of 198.63%.
Score
Financials
7.60
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
9.47
Operational Efficiency
6.62
Growth Potential
7.30
Shareholder Returns
7.14
Forian Inc's Company Valuation
Currency: USD Updated: 2026-05-14The current valuation score of Forian Inc is 8.10, ranking 124 out of 470 in the Software & IT Services industry. Its current P/E ratio is -23.49, which is -245.17% below the recent high of 34.10 and -265.65% above the recent low of -85.89.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 186/470
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-05-14The current earnings forecast score of Forian Inc is 6.00, ranking 381 out of 470 in the Software & IT Services industry. The average price target is 2.10, with a high of 2.10 and a low of 2.10.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
1
analysts
Hold
Current Rating
2.100
Target Price
-3.23%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
246
Total
8
Median
11
Average
Company name
Ratings
Analysts
Forian Inc
FORA
1
Microsoft Corp
MSFT
60
Palo Alto Networks Inc
PANW
58
CrowdStrike Holdings Inc
CRWD
55
Zscaler Inc
ZS
50
Datadog Inc
DDOG
49
1
2
3
...
49
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-05-14The current price momentum score of Forian Inc is 5.17, ranking 421 out of 470 in the Software & IT Services industry. Currently, the stock price is trading between the resistance level at 2.19 and the support level at 2.15, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
2.162
Buy
MA10
2.157
Buy
MA20
2.155
Buy
MA50
2.116
Buy
MA100
2.108
Buy
MA200
2.124
Buy
Institutional Confidence
Currency: USD Updated: 2026-05-14The latest institutional shareholding proportion is 14.91%, representing a quarter-over-quarter decrease of 3.39%. The largest institutional shareholder is James Simons, holding a total of 41.30K shares, representing 0.14% of shares outstanding, with 22.70% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2026-05-14Forian Inc’s latest ESG disclosure leads the Software & IT Services industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.
Score
Beta vs S&P 500 index
0.92
VaR
+6.33%
240-Day Maximum Drawdown
+21.17%
240-Day Volatility
+55.84%
Return
Best Daily Return
60 days
+2.38%
120 days
+3.33%
5 years
+30.12%
Worst Daily Return
60 days
-1.45%
120 days
-5.56%
5 years
-20.41%
Sharpe Ratio
60 days
+1.35
120 days
+0.37
5 years
-0.12
Risk Assessment
Maximum Drawdown
240 days
+21.17%
3 years
+52.57%
5 years
+85.67%
Return-to-Drawdown Ratio
240 days
+0.25
3 years
-0.07
5 years
-0.19
Skewness
240 days
+2.51
3 years
+1.24
5 years
+1.18
Volatility
Realised Volatility
240 days
+55.84%
5 years
+83.52%
Standardised True Range
240 days
+3.47%
5 years
+10.56%
Downside Risk-Adjusted Return
120 days
+41.61%
240 days
+41.61%
Maximum Daily Upside Volatility
60 days
+11.39%
Maximum Daily Downside Volatility
60 days
+9.28%
Liquidity
Average Turnover Rate
60 days
+0.10%
120 days
+0.09%
5 years
--
Turnover Deviation
20 days
+30.57%
60 days
-20.79%
120 days
-24.84%
Peer Comparison
Software & IT Services
Forian Inc
FORA
5.99 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Visa Inc
V
8.75 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
VeriSign, Inc
VRSN
8.56 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Synopsys Inc
SNPS
8.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
A10 Networks Inc
ATEN
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Akamai Technologies Inc
AKAM
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
